Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DuPont de Nemours, Inc. Common Stock (NY:DD)

66.77 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DuPont de Nemours, Inc. Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
What 7 Analyst Ratings Have To Say About DuPont de Nemours
Via Benzinga
The 7 Best Fertilizer Stocks to Buy for 2023
With geopolitical flashpoints creating grave uncertainties in food production, these are the best fertilizer stocks to buy. 
Via InvestorPlace
MMAT Stock Alert: What to Watch at CES 2023
MMAT stock might have comeback potential in 2023 as Meta Materials teams up with a wide variety of tech-focused businesses. 
Via InvestorPlace
US Conglomerate Bids Farewell to Harmful Forever Chemicals
Due to increasing regulatory pressures to fight accumulating harmful substances in the environment and our bodies, 3M Company (NYSE: MMM) committed to stop manufacturing perfluoralkyl and... 
Via Benzinga
A Bullish Sign Appears On DuPont de Nemours's Chart
Via Benzinga
DuPont, Arch Capital, Rockwell Automation And This Agriculture Machinery King: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Stephanie Link of Hightower said DuPont de Nemours, Inc’s (NYSE: DD) stock is down 13% year to date and yields 2%. 
Via Benzinga
Expert Ratings for DuPont de Nemours
Within the last quarter, DuPont de Nemours (NYSE:DD) has observed the following analyst ratings: 
Via Benzinga
This Industrial Stock Looks Dirt Cheap. Is It a Buy?
There is a lot to like about The Chemours Company, but there is one issue that should give investors pause. 
Via The Motley Fool
Warren Buffett's Buying This Passive Income Stock
This dividend-paying company could have the right chemistry for your portfolio. 
Via The Motley Fool
Got $5,000? 3 Top Materials Stocks to Buy for the Long Term
Investors often overlook the mining and materials sector, but there are some tremendous long-term growth stories in it. 
Via The Motley Fool
How Chip Restrictions Against China Could Haunt U.S. Companies
New U.S. trade curbs could fuel retaliatory moves. Here's how they might play out. 
Via Investor's Business Daily
Why Is Petrobras (PBR) Stock Down Today?
Petrobras appears to be under heavy selling pressure on Tuesday. However, PBR stock and its big dividend are mostly to blame. 
Via InvestorPlace
As The Laser Industry Grows, Could This Company Cut A Clean Path To The Top?
As industries change with the needs of the 21st century, innovative laser companies are looking to harness technological advancements to solve key industry problems.  
Via Benzinga
3 Top Industrial Stocks to Buy in November
These stocks have crushed the market in 2022 and look likely to continue. 
Via The Motley Fool
As COP27 Talks Continue, This Blasting Company Is Helping Create A Sustainable New Future
World leaders are gathering for the 27th session of the Conference of the Parties (COP27) in Egypt to discuss the future of the planet.  
Via Benzinga
DuPont, Expeditors International, Planet Fitness And Other Big Gainers From Tuesday
U.S. stocks closed higher on Tuesday, with the Dow Jones surging more than 300 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Disney Earnings And Big Commodity Market Moves: Your Key Update For A Volatile Day
At the closing bell, we saw Disney earnings fall out and we'll be continuing to watch that through the evening into tomorrow morning - along with election results and the impact it could have on... 
Via Talk Markets
What Does DuPont de Nemours's Debt Look Like?
Over the past three months, shares of DuPont de Nemours Inc. (NYSE:DD) increased by 5.15%. Before we understand the importance of debt, let's look at how much debt DuPont de Nemours has. 
Via Benzinga
US Stocks Open Higher As Dow Surges 200 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Tuesday. 
Via Benzinga
US Government May Liquidate Around $4.4B Bitcoin, Cyber Specialists Flag Twitter's Misinformation Concerns, Tesla's Model S, Model X Recall: Top Stories Tuesday, Nov. 08
Reuters 
Via Benzinga
DuPont Clocks 4% Sales Growth In Q3 Backed By Strength In Key End-Markets; Plans $5B Stock Buyback
Via Benzinga
Three Things to Watch this Week
While over four hundred S&P 500 companies have already reported quarterly results, we still have a couple names to keep an eye on this week: Palantir (NYSE: PLTR), Cronos (NASDAQ: CRON), Blue Apron... 
Via Benzinga
Looking Into DuPont de Nemours's Recent Short Interest
DuPont de Nemours's (NYSE:DD) short percent of float has fallen 6.79% since its last report. The company recently reported that it has 7.56 million shares sold short, which is 1.51% of all regular... 
Via Benzinga
Why Rogers Stock Tanked Again on Thursday
Investors are really taking the cancellation of the DuPont deal hard. 
Via The Motley Fool
Check Out What Whales Are Doing With DuPont de Nemours
A whale with a lot of money to spend has taken a noticeably bearish stance on DuPont de Nemours. Looking at options history for DuPont de Nemours (NYSE:DD) we detected 28 strange trades. 
Via Benzinga
Why Rogers Stock Crashed Hard Today
Chemicals giant DuPont was waiting for one final regulatory approval of its pending Rogers buyout, but that hurdle was never cleared. 
Via The Motley Fool
Why Is Rogers Corporation (ROG) Stock Down 44% Today?
Rogers Corporation (ROG) stock is falling hard on Wednesday following confirmation that DuPont (DD) no longer plans to acquire the company. 
Via InvestorPlace
Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02
Reuters 
Via Benzinga
DuPont - Rogers $5.2B Deal Loses Out To Regulatory Hurdles
Via Benzinga
Jim Cramer Likes This Biotechnology Stock: 'It's Not Big, But It's Not Bad'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Royalty Pharma plc (NASDAQ: RPRX) and will stick with it. "It’s not big, but it’s not bad," he added. 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback